Dr Reddy’s gets 4 observations from USFDA for Telangana plant
Team Udayavani, Mar 16, 2018, 5:52 PM IST
New Delhi: Drug major Dr Reddy’s Laboratories today said the US health regulator had issued four observations after inspecting its active pharmaceutical ingredients (API) facility in Telangana.
“The audit of our API Hyderabad plant 1 at Jinnaram Mandal, Medak district, Telangana, by the USFDA has been completed today. We have been issued a Form 483 with four observations which will be addressed comprehensively within stipulated time,” Dr Reddy’s said in a regulatory filing.
As per the USFDA, a Form 483 is issued to a firm’s management at the conclusion of an inspection when investigator has observed any conditions that in its judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
It notifies the company’s management of objectionable conditions.
Dr Reddy’s shares were trading 1.71 per cent down at Rs 2145.95 on the BSE.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Global trends, earnings, FII trading activity major drivers for markets this week: Analysts
India must address ‘inequality’ to become flourishing nation, says Tata Sons chairman
Vi rolls out annual plans with unlimited data usage from midnight till noon every day
Budget Wishlist: Financial sector seeks tax sops, steps to deepen financial markets
India’s manufacturing growth hits 12-month low in Dec amid softer rise in output, new orders
MUST WATCH
Latest Additions
Two held for ‘voyeurism’; college principal among seven booked in Hyderabad
Karnataka govt committed towards providing internal reservation among SCs: Siddaramaiah
Virat Kohli does not deserve place in team, need to end superstar culture: Irfan Pathan
Siddaramaiah challenges Kumaraswamy to prove corruption, commission charges against govt
Malayalam actress Honey Rose accuses man of ‘stalking’, outraging her modesty
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.